Rede Wealth, LLC Adial Pharmaceuticals, Inc. Transaction History

Rede Wealth, LLC

  • $260 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 18, 2022
SELL
$45.0 - $69.0 $684,000 - $1.05 Million
-15,200 Closed
0 $0
Q2 2021

Jul 22, 2021
BUY
$50.5 - $78.25 $10,100 - $15,650
200 Added 1.33%
15,200 $39,000
Q1 2021

May 12, 2021
BUY
$43.25 - $79.75 $648,750 - $1.2 Million
15,000 New
15,000 $36,000

Others Institutions Holding ADIL

# of Institutions
1
Shares Held
5.5K
Call Options Held
0
Put Options Held
0
View Full List

About ADIAL PHARMACEUTICALS, INC.

ADIL Quotes by TradingView
  • Ticker ADIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,854,000
  • Market Cap $27.1M
  • Description
  • Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...
More about ADIL
Track This Portfolio

Track Rede Wealth, LLC Portfolio

Follow Rede Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rede Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rede Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email